Seven Asia-based small caps are falling on October 21: INLIF (NASDAQ:INLF) is trading down 19.59% at $0.2102, Cellyan Biotechnology (NASDAQ:HKPD) is trading down 19.19% at $0.0905, CL Workshop Group (NASDAQ:NWGL) is trading down 16.95% at $0.1264, Roma Green Finance (NASDAQ:ROMA) is trading down 10.93% …
Bending Spoons (NASDAQ:BSP) closed down 0.22% at $45.55 on October 20, but the stock is up 23.14% over the week and 17.25% over the month, with a market capitalization of about $28.93 billion. No company announcement dated to the week was identified, so the …
Bending Spoons (NASDAQ:BSP) and SCWorx (NASDAQ:WORX) both closed the week well ahead, but they could hardly differ more in size. What investors may be missing is that SCWorx has only 742,099 shares outstanding after two reverse splits this year and a market value of …
Better Home & Finance (NASDAQ:BETR) closed up 13.68% at $11.97 on October 20 and is up 32.85% over the week, with a market capitalization of about $228 million. Over the past month the stock is down 2.05%, so the weekly gain is a recovery …
Why Are Better Home & Finance and Real REMAX Group Stocks Up 33% and 21% in a Week, and What Are Investors Overlooking?
Which Penny Stocks Trading Under $1 Face Nasdaq Bid-Price Risk Today, and What Are Investors Missing?
Five life-science names are rising on October 21: China SXT Pharmaceuticals (NASDAQ:SXTC) is trading up 38.74% at $0.0906, Baird Medical (NASDAQ:BDMD) is trading up 13.97% at $0.5489, NeuroSense Therapeutics (NASDAQ:NRSN) is trading up 12.97% at $2.70, Pluri (NASDAQ:PLUR) is trading up 10.00% at $0.99 …
What Are Investors Missing as Alpha Teknova, GT Biopharma, Advanced Biomed, iTonic Holdings and NewGenIvf Group Lead Biotech Stocks Lower Today?
Black Rock Coffee Bar (NASDAQ:BRCB) closed up 1.77% at $8.62 on October 20 and is up 19.89% over the week, with a market capitalization of about $432 million. The stock has gained 21.92% over the past month. No company announcement dated to the week …
What Is Driving Bloomin' Brands' 17.23% Weekly Rally, and Are Investors Overlooking the Margin Story?